GIC Private Ltd sells $274.8 million in Medline (MDLN) shares

Singapore-based GIC Private Ltd recently sold a significant block of Medline shares, disposing of 7,816,987 shares at $35.15 each, totaling $274.8 million. This follows a 24.5% decline in Medline's stock over the past six months. The sale comes as Medline continues to operate within the Healthcare Equipment & Supplies industry, generating $29.94 billion in revenue with a 12% growth rate.

GIC Private Ltd, a major shareholder and director of Medline, currently holds 16.45 million shares directly and 69.41 million shares indirectly through Hux Investment Pte. Ltd. The company's shares remain undervalued according to InvestingPro analysis and are considered a prominent player in the industry. Medline reported second-quarter 2026 revenue of $7.7 billion, a 12% increase from the previous year, with adjusted earnings of $0.50 per share.

However, some investors express concern over a lower full-year profit outlook and rising costs. Analysts have maintained a generally positive outlook for Medline, with BTIG maintaining a Buy rating and Tigress Financial Partners lowering their price target for the stock.